Connect your AI

GRAIL, Inc. GRAL Proceeds from issuance of common stock relating to employee stock plans

Proceeds from issuance of common stock relating to employee stock plans at other companies

Tango TherapeuticsTNGX

——

IncyteINCY

——

Other financials

Income statement

Revenue$40.8M+28.1%

Operating income-$135.8M+11.6%

Net income-$93.2M+12.3%

EPS (diluted)-$2.29+26.1%

Balance sheet

Cash & equivalents$76.3M-44.4%

Total debt$51.0M-20.7%

Total equity$2.5B+3.6%

Total assets$2.8B-1.5%

Cash flow

Operating cash flow-$87.0M+8.4%

CapEx$503.0K+711%

Free cash flow-$87.5M+8.0%

Valuation

Market cap$2.62B+145%

Enterprise value$2.6B+164%

P/S16.8×+8.6×

Profitability

Operating margin-348.7%-153pp

Net margin-253.2%-115pp

FCF margin-187.2%-60.4pp

Returns & leverage

Return on equity-16.1%—

Debt / equity0×0.0×

Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: GRAIL, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s proceeds from issuance of common stock relating to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is GRAIL, Inc.'s proceeds from issuance of common stock relating to employee stock plans?: GRAIL, Inc. (GRAL) reported proceeds from issuance of common stock relating to employee stock plans of $1.13M in Q4 2025.